Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Institute

Showing 12 out of 58 results
Prostate Cancer cell image taken using a Scanning Electron Microscope

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

by Amy Warnock | News | 29 February 2024

29 February 2024

More Research, Less Cancer over an image of a researcher

Cancer Research UK has joined forces with a coalition of the world’s most renowned voices in the research community to call on high-value donors and philanthropists to help tackle cancer. Cancer Research UK has joined forces with a coalition of the world’s most renowned voices in the research community to call on high-value donors and philanthropists to help tackle cancer.

by Cancer Research UK | News | 22 February 2024

22 February 2024

Cells with nuclei in blue and mitochondria (energy factories) in green.

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

by Tim Gunn | Analysis | 31 January 2024

31 January 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Lab Tour at Cancer Research UK's Manchester Institute

Welcoming our corporate partners, supporters, and ambassadors to our new building at the Cancer Research UK Manchester Institute. Welcoming our corporate partners, supporters, and ambassadors to our new building at the Cancer Research UK Manchester Institute.

by Alice Hilton | Philanthropy and partnerships | 9 November 2023

9 November 2023

A researcher looking at slides under a microscope

Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important

by Michelle Mitchell | Opinion | 21 September 2023

21 September 2023

CRUK Scotland Institute

Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute

by Amy Warnock | News | 20 September 2023

20 September 2023

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Lung adenocarcinoma cells

Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers. Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers.

by Jacob Smith | Analysis | 1 June 2023

1 June 2023

Breast magnetic resonance image, or MRI. The bright white dot in the larger images is stage one breast cancer.

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

by Jacob Smith | Analysis | 9 May 2023

9 May 2023